NCT03172520 is a NA clinical trial of APS electrode in Parotid Gland Disorders, sponsored by Mayo Clinic.

Who is sponsoring NCT03172520?

NCT03172520 is sponsored by Mayo Clinic.

What drugs are being tested in NCT03172520?

Interventions in NCT03172520: APS electrode, Facial Nerve Monitor.

What condition does NCT03172520 study?

NCT03172520 studies Parotid Gland Disorders.

Is NCT03172520 still recruiting?

NCT03172520 is currently terminated. Last updated 18 January 2020.

Are results published for NCT03172520?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-01-18 · How we verify

NCT03172520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy

Terminated NA Results posted Last updated 18 January 2020

What this trial tests

NA trial testing APS electrode in Parotid Gland Disorders in 10 participants. Terminated before completion.

Timeline

1 January 2017

Primary endpoint
30 June 2017

30 December 2017

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	1 January 2017
Primary completion	30 June 2017
Estimated completion	30 December 2017
Sites	1 location across United States

Drugs / interventions tested

APS electrode
Facial Nerve Monitor

Conditions studied

Parotid Gland Disorders — all drugs for Parotid Gland Disorders →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Parotid Gland Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03172520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03172520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing